European Equities Traded in the US as American Depositary Fall Sharply in Tuesday Trading

European equities traded in the US as American depositary receipts were tracking sharply lower late Tuesday morning, declining 1.71% to 1,313.74 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by medical device maker EDAP TMS (EDAP) and biopharmaceutical company Cellectis (CLLS), which rose 4.4% and 1.1% respectively. They were followed by accommodations booking platform trivago (TRVG), which rose 0.6%.

The decliners from continental Europe were led by biotech firm Evaxion Biotech (EVAX) and biopharmaceutical company DBV Technologies (DBVT), which fell 1.7% and 3.7% respectively. They were followed by oil and gas company TotalEnergies (TTE) and pharmaceutical company Novo Nordisk (NVO), which dropped 3.2% and 2.6% respectively.

From the UK and Ireland, the gainers were led by software firm Endava (DAVA) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which advanced 7.4% and 2.5% respectively. They were followed by biopharmaceutical companies NuCana (NCNA) and TC Biopharm (TCBP), which increased 2% and 1.9% respectively.

The decliners from the UK and Ireland were led by telecommunications operator Vodafone Group (VOD) and biopharmaceutical company Mereo BioPharma Group (MREO), which lost 7.9% and 5.1% respectively. They were followed by insurance firm Prudential (PUK) and pharmaceutical Silence Therapeutics (SLN), which dropped 5% and 4% respectively.